Repositório Covid-1919/09/2022 Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike proteinSignificanceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires fusion of viral and host membranes, mediated by the viral...18/09/2022 Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapyAbstractCoronavirus disease 2019 (COVID-19) remains a major public health concern, and vaccine unavailability, hesitancy, or failure underscore the need...17/09/2022 A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer responseSerological tests for SARS-CoV-2 specific antibodies can used for public health surveillance and vaccine development.•17/09/2022 Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochAbstractThe effectiveness of bebtelovimab in real-world settings has not been assessed. In this retrospective cohort study of 3607 high-risk...17/09/2022 A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantAbstractThe recently emerged Omicron (B.1.1.529) variant has rapidly surpassed Delta to become the predominant circulating SARS-CoV-2 variant, given the...16/09/2022 A Bivalent Omicron-Containing Booster Vaccine against Covid-19AbstractThe safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known.16/09/2022 Use of low molecular weight heparin and hemoglobin fall in COVID-19 patients: A STROBE-compliant studyAbstractIn patients with coronavirus disease 2019 (COVID-19), anticoagulation was suggested as a mitigating strategy. However, little research has been...14/09/2022 Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19AbstractThe coronavirus disease 2019 (COVID-19) is a pandemic that has severely posed substantial health challenges and claimed millions of...14/09/2022 Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialSummaryBackgroundBNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals...12/09/2022 Spatial and temporal dynamics of SARS‐CoV‐2: Modeling, analysis and simulationPropose a novel reaction-diffusion viral infection model to characterize the infection process.•12/09/2022 Zinc and COVID-19: Immunity, Susceptibility, Severity and InterventionAbstract12/09/2022 Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialSummaryBackgroundBNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals...
19/09/2022 Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike proteinSignificanceSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection requires fusion of viral and host membranes, mediated by the viral...
18/09/2022 Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapyAbstractCoronavirus disease 2019 (COVID-19) remains a major public health concern, and vaccine unavailability, hesitancy, or failure underscore the need...
17/09/2022 A review post-vaccination SARS-CoV-2 serological test: Method and antibody titer responseSerological tests for SARS-CoV-2 specific antibodies can used for public health surveillance and vaccine development.•
17/09/2022 Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron EpochAbstractThe effectiveness of bebtelovimab in real-world settings has not been assessed. In this retrospective cohort study of 3607 high-risk...
17/09/2022 A self-assembled trimeric protein vaccine induces protective immunity against Omicron variantAbstractThe recently emerged Omicron (B.1.1.529) variant has rapidly surpassed Delta to become the predominant circulating SARS-CoV-2 variant, given the...
16/09/2022 A Bivalent Omicron-Containing Booster Vaccine against Covid-19AbstractThe safety and immunogenicity of the bivalent omicron-containing mRNA-1273.214 booster vaccine are not known.
16/09/2022 Use of low molecular weight heparin and hemoglobin fall in COVID-19 patients: A STROBE-compliant studyAbstractIn patients with coronavirus disease 2019 (COVID-19), anticoagulation was suggested as a mitigating strategy. However, little research has been...
14/09/2022 Consensus docking and MM-PBSA computations identify putative furin protease inhibitors for developing potential therapeutics against COVID-19AbstractThe coronavirus disease 2019 (COVID-19) is a pandemic that has severely posed substantial health challenges and claimed millions of...
14/09/2022 Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialSummaryBackgroundBNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals...
12/09/2022 Spatial and temporal dynamics of SARS‐CoV‐2: Modeling, analysis and simulationPropose a novel reaction-diffusion viral infection model to characterize the infection process.•
12/09/2022 Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trialSummaryBackgroundBNT162b2, an mRNA vaccine against COVID-19, is being utilised worldwide, but immunogenicity and safety data in Chinese individuals...